Probiotics function and modulation of the immune system in allergic diseases
Main Article Content
Keywords
Allergy, Immunotherapy, Asthma, Cell biology, Clinical trials
Abstract
Allergic diseases have been a global problem over the past few decades. The effect of allergic diseases on healthcare systems and society is generally remarkable and is considered as one of the most common causes of chronic and hospitalized disease. The functional ability of probiotics to modulate the innate/acquired immune system leads to the initiation of mucosal/systemic immune responses. Gut microbiota plays a beneficial role in food digestion, development of the immune system, control/growth of the intestinal epithelial cells and their differentiation. Prescribing probiotics causes a significant change in the intestinal microflora and modulates cytokine secretion, including networks of genes, TLRs, signaling molecules and increased intestinal IgA responses. The modulation of the Th1/Th2 balance is done by probiotics, which suppress Th2 responses with shifts to Th1 and thereby prevent allergies. In general, probiotics are associated with a decrease in inflammation by increasing butyrate production and induction of tolerance with an increase in the ratio of cytokines such as IL-4, IL-10/IFN-, Treg/TGF-, reducing serum eosinophil levels and the expression of metalloproteinase-9 which contribute to the improvement of the allergic disease’s symptoms. Finally, it can be said that the therapeutic approach to immunotherapy and the reduction of the risk of side effects in the treatment of allergic diseases is the first priority of treatment and the final approach that completes the first priority in maintaining the condition and sustainability of the tolerance along with the recovery of the individual.
References
1. Ring J. Davos declaration: allergy as a global problem. Allergy. 2012;67(2):141-3.
2. Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax. 2007;62(1):91-6.
3. Ring J, Krämer U, Schäfer T, Behrendt H. Why are allergies increasing? Curr Opin Immunol. 2001;13(6):701-8.
4. Yates A, Callard R, Stark J. Combining cytokine signalling with T-bet and GATA-3 regulation in Th1 and Th2 differentiation: a model for cellular decision-making. J Theoret Biol. 2004;231(2):181-96.
5. Romagnani S. Regulation of the T cell response. Clin Exp Allergy. 2006;36(11):1357-66.
6. Dietert RR, Zelikoff JT. Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma. Birth Defects Res Part B: Dev Reprod Toxicol. 2008;83(6):547-60.
7. Mikocka-Walus A, Pittet V, Rossel JB, von Känel R, Anderegg C, Bauerfeind P. Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2016;14(6), 829-835.e1.
8. Papadopoulos N, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R. International consensus on (ICON) pediatric asthma. Allergy. 2012;67(8):976-97.
9. Pawankar R. Allergic diseases and asthma: a global public health concern and a call to action. BioMed Central; 2014.
10. Pawankar R, Canonica GW, Holgate ST, Lockey RF. Allergic diseases and asthma: a major global health concern. Curr Opin Allergy Clin Immunol. 2012;12(1):39-41.
11. Sheehan WJ, Phipatanakul W. Difficult to control asthma: epidemiology and its link with environmental factors. Curr Opin Allergy Clin Immunol. 2015;15(5):397.
12. Anandan C, Nurmatov U, Van Schayck OCP, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy. 2010;65(2):152-67.
13. Ramírez-Soto M, Bedolla-Barajas M, González-Mendoza T. Prevalence of asthma, allergic rhinitis and atopic dermatitis in school children of the Mexican Bajío region. Rev Alergia Mexico. 2018;65(4):372-8.
14. Bach J-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911-20.
15. Yousefi B, Mohammadlou M, Abdollahi M, Salek Farrokhi A, Karbalaei M, Keikha M, et al. Epigenetic changes in gastric cancer induction by Helicobacter pylori. J Cell Physiol. 2019;234(12):21770-84.
16. Vissers Y, Wichers H, Savelkoul H. Influence of food processing, digestion and the food matrix on allergenicity & cellular measures of allergenicity. In: Multidisciplinary approaches to allergies. Springer; 2012. p. 203-27.
17. Born WK, Huang Y, Reinhardt RL, Huang H, Sun D, O’Brien, et al. ı T cells and B cells. In: Advances in immunology. Elsevier; 2017. p. 1-45.
18. Sur DK, Scandale S. Treatment of allergic rhinitis. South Afr Fam Pract. 2010:398-403.
19. Yánez ˜ A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2002;89(5):479-84.
20. Rajakulendran M, Tham EH, Soh JY, Van Bever HP. Novel strategies in immunotherapy for allergic diseases. Asia Pac Allergy. 2018;8(2).
21. Moote W, Kim H. Allergen-specific immunotherapy. Allergy Asthma Clin Immunol. 2011;7(1): S5.
22. James C, Bernstein DI. Allergen immunotherapy: an updated review of safety. Curr Opin Allergy Clin Immunol. 2017;17(1):55.
23. Pae H-O, Jeong SO, Koo BS, Ha HY, Lee KM, Chung HT, et al. Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but down-regulates the pro-inflammatory cyclooxygenase2 and inducible nitric oxide synthase expression in RAW264. 7 macrophages. Biochem Biophys Res Commun. 2008;371(3):361-5.
24. Wu AY-Y. Immunotherapy-Vaccines for allergic diseases. J Thorac Dis. 2012;4(2):198.
25. Marth K, Focke-ejkl M, Lupinek C, Valenta R, Niederberger V. Allergen peptides, recombinant allergens and hypoallergens for allergen specific immunotherapy. Curr Treat Opt Allergy. 2014;1(1):91-106.
26. Keikha M, Eslami M, Yousefi B, Ghasemian A, Karbalaei M. Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection. J Cell Physiol. 2019;234(12):21460-70.
27. Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M, et al. Update on allergy immunotherapy: American academy of allergy, asthma & immunology/European academy of allergy and clinical immunology/PRACTALL consensus report. J Allergy Clin Immunol. 2013;131(5), 1288-1296.e3.
28. Bitton A, Ratcliffe HL, Veillard JH, Kress DH, Barkley S, Kimball M, et al. Primary health care as a foundation for strengthening health systems in low-and middle-income countries. J Gen Intern Med. 2017;32(5):566-71.
29. Hillman ET, Lu H, Yao T, Nakatsu CH. Microbial ecology along the gastrointestinal tract. Microbes Environm. 2017:ME17017.
30. Salek Farrokhi A, Darabi N, Yousefi B, Askandar RH, Shariati M, Eslami M, et al. Is it true that gut microbiota is considered as panacea in cancer therapy? J Cell Physiol. 2019;234(9):14941-50.
31. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121-41.
32. Dimeloe S, Nanzer A, Ryanna K, Hawrylowicz C. Regulatory T cells, inflammation and the allergic response-the role of glucocorticoids and vitamin D. J Steroid Biochem Mol Biol. 2010;120(2-3):86-95.
33. Houghteling PD, Walker WA. Why is initial bacterial colonization of the intestine important to the infant’s and child’s health? J Pediatr Gastroenterol Nutr. 2015;60(3):294.
34. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313.
35. Tlaskalová-Hogenová H, ˇStepánková ˇ R, Kozáková H, Hudcovic T, Vannucci L, Tuˇcková L, et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011;8(2):110.
36. Kobyliak N, Falalyeyeva T, Bodnar P, Beregova T. Probiotics supplemented with omega-3 fatty acids are more effective for hepatic steatosis reduction in an animal model of obesity. Probiot Antimicrob Proteins. 2017;9(2):123-30.
37. Kobyliak N, Falalyeyeva T, Beregova T, Spivak M. Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition. Endokrynol Polska. 2017;68(6):659-67.
38. Kobyliak N, Virchenko O, Falalyeyeva T, Kondro M, Beregova T, Bodnar P, et al. Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats. Biomed Pharmacother. 2017;90:608-14.
39. Ghasemian A, Eslami M, Shafiei M, Najafipour S, Rajabi A. Probiotics and their increasing importance in human health and infection control. Rev Med Microbiol. 2018;29(4): 153-8.
40. Yousefi B, Eslami M, Ghasemian A, Kokhaei P, Salek Farrokhi A, Darabi N, et al. Probiotics importance and their immunomodulatory properties. J Cell Physiol. 2019;234(6): 8008-18.
41. Eslami M, Yousefi B, Kokhaei P, Moghadas AJ, Moghadam BS, Arabkari V, et al. Are probiotics useful for therapy of Helicobacter pylori diseases? Comparat Immunol Microbiol Infect Dis. 2019;64:99-108.
42. Yousefi B, Eslami M, Ghasemian A, Kokhaei P, Sadeghnejhad A. Probiotics can really cure an autoimmune disease? Gene Rep. 2019:100364.
43. Eslami M, Yousefi B, Kokhaei P, Hemati M, Nejad ZR, Arabkari V, Namdar A, et al. Importance of probiotics in the prevention and treatment of colorectal cancer. J Cell Physiol. 2019;234(10):17127-43.
44. Ursell LK, Clemente JC, Rideout JR, Gevers D, Caporaso JG, Knight R, et al. The interpersonal and intrapersonal diversity of human associated microbiota in key body sites. J Allergy Clin Immunol. 2012;129(5):1204-8.
45. Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF, et al. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med. 2014;20(9):509-18.
46. Sommer F, Bäckhed F. The gut microbiota--masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227.
47. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268-73.
48. Gaggìa F, Mattarelli P, Biavati B. Probiotics and prebiotics in animal feeding for safe food production. Int J Food Microbiol. 2010;141:S15-28.
49. Canny GO, McCormick BA. Bacteria in the intestine, helpful residents or enemies from within? Infect Immun. 2008;76(8):3360-73.
50. Hotel ACP, Cordoba A. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Prevention. 2001;5(1):1-10.
51. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015;60 suppl 2:S129-34.
52. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr. 2006;83(6):1256-64.
53. Fontana L, Bermudez-rito M, Plaza-iaz J, Munoz-uezada S, Gil A. Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr. 2013;109(S2): S35-50.
54. Reid G. Probiotics and prebiotics---progress and challenges. Int Dairy J. 2008;18(10-11):969-75.
55. Aureli P, Capurso L, Castellazzi AM, Clerici M, Giovannini M, Morelli L. Probiotics and health: an evidence-based review. Pharmacol Res. 2011;63(5):366-76.
56. MacDonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307(5717):1920-5.
57. Todorov SD, Furtado DN, Saad SMI, Gombossy de Melo Franco BD. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain. N Microbiol. 2011;34(4):357-70.
58. Ohland CL, MacNaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol-Gastrointest Liver Physiol. 2010;298(6): G807-19.
59. Resta-Lenert S, Barrett K. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 2003;52(7):988-97.
60. Guarner F, Malagelada J-R. Gut flora in health and disease. Lancet. 2003;361(9356):512-9.
61. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short-chain fatty acids. Nutrients. 2011;3(10):858-76.
62. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003;133(7):2485S-93S.
63. Toma MM, Pokrotnieks J. Probiotics as functional food: microbiological and medical aspects. Acta Univ Latviensis. 2006;710:117-29.
64. Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M. Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J Leukoc Biol. 2008;84(2):468-76.
65. Gourbeyre P, Denery S, Bodinier M. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol. 2011;89(5):685-95.
66. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology. 2004;112(3):352-63.
67. Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol. 2005;174(8):4453-60.
68. Toh ZQ, Anzela A, Tang ML, Licciardi PV. Probiotic therapy as a novel approach for allergic disease. Front Pharmacol. 2012;3:171.
69. Bager P, Melbye M, Rostgaard K, Benn CS, Westergaard T. Mode of delivery and risk of allergic rhinitis and asthma. J Allergy Clin Immunol. 2003;111(1):51-6.
70. Illi S, von Mutius E, Lau S, Nickel R, Grüber C, Niggemann B, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004;113(5):925-31.
71. Iannitti T, Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr. 2010;29(6):701-25.
72. Hougee S, Vriesema AJM, Wijering SC, Knippels LMJ, Folkerts G, Nijkamp FP, et al. Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. Int Arch Allergy Immunol. 2010;151(2):107-17.
73. Repa A, Grangette C, Daniel C, Hochreiter R, HoffmannSommergruber K, Thalhamer J, et al. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine. 2003;22(1):87-95.
74. Kim H, Kwack K, Kim DY, Ji GE. Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model. FEMS Immunol Med Microbiol. 2005;45(2):259-67.
75. Kawase M, He F, Kubota A, Hata JY, Kobayakawa SI, Hiramatsu M, et al. Inhibitory effect of Lactobacillus gasseri TMC0356 and Lactobacillus GG on enhanced vascular permeability of nasal mucosa in experimental allergic rhinitis of rats. Biosci Biotechnol Biochem. 2006;70(12):3025-30.
76. Forsythe P, Inman MD, Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med. 2007;175(6):561-9.
77. Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, Jaudszus A, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy. 2007;37(4):498-505.
78. Ogawa T, Hashikawa S, Asai Y, Sakamoto H, Yasuda K, Makimura Y, et al. A new synbiotic, Lactobacillus casei subsp. casei together with dextran, reduces murine and human allergic reaction. FEMS Immunol Med Microbiol. 2006;46(3):400-9.
79. Takahashi N, Kitazawa H, Iwabuchi N, Xiao JZ, Miyaji K, Iwatsuki, et al. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model. Clin Exp Immunol. 2006;145(1):130-8.
80. Peng S, Lin J-Y, Lin M-Y. Antiallergic effect of milk fermented with lactic acid bacteria in a murine animal model. J Agric Food Chem. 2007;55(13):5092-6.
81. Ezendam J, van Loveren H. Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice. Br J Nutr. 2008;99(1):83-90.
82. Lim LH, Li HY, Huang CH, Lee BW, Lee YK, Chua KY, et al. The effects of heat-killed wild-type Lactobacillus casei Shirota on allergic immune responses in an allergy mouse model. Int Arch Allergy Immunol. 2009;148(4):297-304.
83. Inoue Y, Iwabuchi N, Xiao JZ, Yaeshima T, Iwatsuki K. Suppressive effects of Bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model. Biol Pharm Bull. 2009;32(4):760-3.
84. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105(5):755-64.
85. Ohshima-Terada Y, Higuchi Y, Kumagai T, Hagihara A, Nagata M. Complementary effect of oral administration of L actobacillus paracasei K 71 on canine atopic dermatitis. Vet Dermatol. 2015;26(5):350-e75.
86. Thomas DJ, Husmann RJ, Villamar M, Winship TR, Buck RH, Zuckermann FA, et al. Lactobacillus rhamnosus HN001 attenuates allergy development in a pig model. PLoS One. 2011;6(2):e16577.
87. Jang S-O, Kim HJ, Kim YJ, Kang MJ, Kwon JW, Seo JH, et al. Asthma prevention by Lactobacillus rhamnosus in a mouse model is associated with CD4+ CD25+ Foxp3+ T cells. Allergy Asthma Immunol Res. 2012;4(3):150-6.
88. Tang ML, Ponsonby AL, Orsini F, Tey D, Robinson M, Su EL, et al. Administration of a probiotic with peanut oral immunotherapy: a randomized trial. J Allergy Clin Immunol. 2015;135(3), 737-744.e8.
89. Sistek D, et al. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin Exp Allergy. 2006;36(5):629-33.
90. Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005;60(4):494-500.
91. Ooi L-G, Liong M-T. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci. 2010;11(6):2499-522.
92. Yes¸ilova Y, C¸alka Ö, Akdeniz N, Berktas¸ M. Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol. 2012;24(2):189-93.
93. Niers LE, Timmerman HM, Rijkers GT, van Bleek GM, van Uden NO, Knol EF, et al. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy. 2005;35(11):1481-9.
94. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119(1):184-91.
95. Inoue Y, Torii A, Itoh K, Urisu A, Terada A, Fujisawa T, et al. Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults: a double-blind, randomized, clinical trial. Int Arch Allergy Immunol. 2014;165(4):247-54.
96. Prakoeswa C, Herwanto N, Prameswari R, Astari L, Sawitri S, Hidayati AN, et al. Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Benefic Microbes. 2017;8(5):833-40.
97. Simpson MR, Dotterud CK, Storrø O, Johnsen R, Øien T. Perinatal probiotic supplementation in the prevention of allergy-related disease: 6 year follow up of a randomised controlled trial. BMC Dermatol. 2015;15(1):13.
98. Wang IJ, Wang JY. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clin Exp Allergy. 2015;45(4):779-87.
99. Canani RB, Sangwan N, Stefka AT, Nocerino R, Paparo L, Aitoro R, et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J. 2016;10(3):742.
100. Dupont C, Hol J, Nieuwenhuis EE. An extensively hydrolysed casein-based formula for infants with cows’ milk protein allergy: tolerance/hypo-allergenicity and growth catch-up. Br J Nutr. 2015;113(7):1102-12.
101. Del Giudice MM, Indolfi C, Capasso M, Maiello N, Decimo F, Ciprandi G, et al. Bifidobacterium mixture (B longum BB536, B infantis M 63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma. Italian J Pediatr. 2017;43(1):25.
102. del Giudice MM, Maiello N, Allegorico A, Iavarazzo L, Capasso M, Capristo C, et al. Lactobacillus reuteri DSM 17938 plus vitamin D3 as ancillary treatment in allergic children with asthma. Ann Allergy Asthma Immunol. 2016;117(6):710-2.
103. Dennis-Wall JC, Culpepper T, Nieves C Jr, Rowe CC, Burns AM, Rusch CT, et al. Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial. Am J Clin Nutr. 2017;105(3):758-67.
104. Jerzynska J, Stelmach W, Balcerak J, Woicka-Kolejwa K, Rychlik B, Blauz A, et al. Effect of Lactobacillus rhamnosus GG and vitamin D supplementation on the immunologic effectiveness of grass-specific sublingual immunotherapy in children with allergy. Allergy Asthma Proc. 2016;37(4):324-34.
105. Watts AM, Cox AJ, Smith PK, Besseling-van der Vaart I, Cripps AW, West NP, et al. A specifically designed multispecies probiotic supplement relieves seasonal allergic rhinitis symptoms. J Alternat Complement Med. 2018;24(8):833-40.
106. Liao H-Y, Tao L, Zhao J, Qin J, Zeng GC, Cai SW, et al. Clostridium butyricum in combination with specific immunotherapy converts antigen-specific B cells to regulatory B cells in asthmatic patients. Sci Rep. 2016;6:20481.
107. Smith TD, Watt H, Gunn L, Car J, Boyle RJ. Recommending oral probiotics to reduce winter antibiotic prescriptions in people with asthma: a pragmatic randomized controlled trial. Ann Fam Med. 2016;14(5):422-30.
108. Kim JY, Choi YO, Ji GE. Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. J Microbiol Biotechnol. 2008;18(8):1393-400.
109. Yu J, Jang SO, Kim BJ, Song YH, Kwon JW, Kang MJ, et al. The Effects of Lactobacillus rhamnosus on the Prevention of Asthma in a Murine Model. Allergy Asthma Immunol Res. 2010;2(3):199-205.
110. Marsella R, Santoro D, Ahrens K. Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects. Vet Immunol Immunopathol. 2012;146(2):185-9.
111. Kim HJ, Kim YJ, Lee SH, Yu J, Jeong SK, Hong SJ, et al. Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via CD4(+)CD25(+)Foxp3(+) Tregs. Clin Immunol. 2014;153(1):178-86.
112. Wu CT, et al. Effects of immunomodulatory supplementation with Lactobacillus rhamnosus on airway inflammation in a mouse asthma model. J Microbiol Immunol Infect. 2016;49(5):625-35.
113. Liu MY, Yang ZY, Dai WK, Huang JQ, Li YH, Zhang J, et al. Protective effect of Bifidobacterium infantis CGMCC313-2 on ovalbumin-induced airway asthma and beta-lactoglobulin induced intestinal food allergy mouse models. World J Gastroenterol. 2017;23(12):2149-58.
114. Wang X, Hui Y, Zhao L, Hao Y, Guo H, Ren F, et al. Oral administration of Lactobacillus paracasei L9 attenuates PM2.5- induced enhancement of airway hyperresponsiveness and allergic airway response in murine model of asthma. PloS one. 2017;12(2):e0171721.
115. Holowacz S, Guinobert I, Guilbot A, Hidalgo S, Bisson JF. A mixture of five bacterial strains attenuates skin inflammation in mice. Antiinflamm Antiallergy Agents Med Chem. 2018;17(2):125-37.
116. Zhang J, Ma JY, Li QH, Su H, Sun X. Lactobacillus rhamnosus GG induced protective effect on allergic airway inflammation is associated with gut microbiota. Cell Immunol. 2018;332:77-84.
117. Kim IS, Lee SH, Kwon YM, Adhikari B, Kim JA, Yu DY, et al. Oral Administration of beta-Glucan and Lactobacillus plantarum Alleviates Atopic Dermatitis-Like Symptoms. J Microbiol Biotechnol. 2019;29(11):1693-706.
118. Anatriello E, Cunha M, Nogueira J, Carvalho JL, Sá AK, Miranda M, et al. Oral feeding of Lactobacillus bulgaricus N45.10 inhibits the lung inflammation and airway remodeling in murine allergic asthma: Relevance to the Th1/Th2 cytokines and STAT6/T-bet. Cell Immunol. 2019;341:103928.
119. Wang W, Luo X, Zhang Q, He X, Zhang Z, Wang X, et al. Bifidobacterium infantis relieves allergic asthma in mice by regulating Th1/Th2. Med Sci Monitor. 2020;26:e920583.
120. Marlow G, Han DY, Wickens K, Stanley T, Crane J, Mitchell EA, et al. Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors. Pediatr Allergy Immunol. 2015;26(3):262-71.
121. Scalabrin D, Harris C, Johnston WH, Berseth CL. Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up. Eur J Pediatr. 2017;176(2):217-24.
122. Cabana MD, McKean M, Caughey AB, Fong L, Lynch S, Wong A, et al. Early probiotic supplementation for eczema and asthma prevention: a randomized controlled trial. Pediatrics. 2017;140(3).
123. Harata G, Kumar H, He F, Miyazawa K, Yoda K, Kawase M, et al. Probiotics modulate gut microbiota and health status in Japanese cedar pollinosis patients during the pollen season. Eur J Nutr. 2016:56.
124. Ro ADB, Simpson MR, Rø TB, Storrø O, Johnsen R, Videm V, et al. Reduced Th22 cell proportion and prevention of atopic dermatitis in infants following maternal probiotic supplementation. Clin Exp Allergy. 2017;47(8):1014-21.
2. Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax. 2007;62(1):91-6.
3. Ring J, Krämer U, Schäfer T, Behrendt H. Why are allergies increasing? Curr Opin Immunol. 2001;13(6):701-8.
4. Yates A, Callard R, Stark J. Combining cytokine signalling with T-bet and GATA-3 regulation in Th1 and Th2 differentiation: a model for cellular decision-making. J Theoret Biol. 2004;231(2):181-96.
5. Romagnani S. Regulation of the T cell response. Clin Exp Allergy. 2006;36(11):1357-66.
6. Dietert RR, Zelikoff JT. Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma. Birth Defects Res Part B: Dev Reprod Toxicol. 2008;83(6):547-60.
7. Mikocka-Walus A, Pittet V, Rossel JB, von Känel R, Anderegg C, Bauerfeind P. Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2016;14(6), 829-835.e1.
8. Papadopoulos N, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R. International consensus on (ICON) pediatric asthma. Allergy. 2012;67(8):976-97.
9. Pawankar R. Allergic diseases and asthma: a global public health concern and a call to action. BioMed Central; 2014.
10. Pawankar R, Canonica GW, Holgate ST, Lockey RF. Allergic diseases and asthma: a major global health concern. Curr Opin Allergy Clin Immunol. 2012;12(1):39-41.
11. Sheehan WJ, Phipatanakul W. Difficult to control asthma: epidemiology and its link with environmental factors. Curr Opin Allergy Clin Immunol. 2015;15(5):397.
12. Anandan C, Nurmatov U, Van Schayck OCP, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy. 2010;65(2):152-67.
13. Ramírez-Soto M, Bedolla-Barajas M, González-Mendoza T. Prevalence of asthma, allergic rhinitis and atopic dermatitis in school children of the Mexican Bajío region. Rev Alergia Mexico. 2018;65(4):372-8.
14. Bach J-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911-20.
15. Yousefi B, Mohammadlou M, Abdollahi M, Salek Farrokhi A, Karbalaei M, Keikha M, et al. Epigenetic changes in gastric cancer induction by Helicobacter pylori. J Cell Physiol. 2019;234(12):21770-84.
16. Vissers Y, Wichers H, Savelkoul H. Influence of food processing, digestion and the food matrix on allergenicity & cellular measures of allergenicity. In: Multidisciplinary approaches to allergies. Springer; 2012. p. 203-27.
17. Born WK, Huang Y, Reinhardt RL, Huang H, Sun D, O’Brien, et al. ı T cells and B cells. In: Advances in immunology. Elsevier; 2017. p. 1-45.
18. Sur DK, Scandale S. Treatment of allergic rhinitis. South Afr Fam Pract. 2010:398-403.
19. Yánez ˜ A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2002;89(5):479-84.
20. Rajakulendran M, Tham EH, Soh JY, Van Bever HP. Novel strategies in immunotherapy for allergic diseases. Asia Pac Allergy. 2018;8(2).
21. Moote W, Kim H. Allergen-specific immunotherapy. Allergy Asthma Clin Immunol. 2011;7(1): S5.
22. James C, Bernstein DI. Allergen immunotherapy: an updated review of safety. Curr Opin Allergy Clin Immunol. 2017;17(1):55.
23. Pae H-O, Jeong SO, Koo BS, Ha HY, Lee KM, Chung HT, et al. Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but down-regulates the pro-inflammatory cyclooxygenase2 and inducible nitric oxide synthase expression in RAW264. 7 macrophages. Biochem Biophys Res Commun. 2008;371(3):361-5.
24. Wu AY-Y. Immunotherapy-Vaccines for allergic diseases. J Thorac Dis. 2012;4(2):198.
25. Marth K, Focke-ejkl M, Lupinek C, Valenta R, Niederberger V. Allergen peptides, recombinant allergens and hypoallergens for allergen specific immunotherapy. Curr Treat Opt Allergy. 2014;1(1):91-106.
26. Keikha M, Eslami M, Yousefi B, Ghasemian A, Karbalaei M. Potential antigen candidates for subunit vaccine development against Helicobacter pylori infection. J Cell Physiol. 2019;234(12):21460-70.
27. Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M, et al. Update on allergy immunotherapy: American academy of allergy, asthma & immunology/European academy of allergy and clinical immunology/PRACTALL consensus report. J Allergy Clin Immunol. 2013;131(5), 1288-1296.e3.
28. Bitton A, Ratcliffe HL, Veillard JH, Kress DH, Barkley S, Kimball M, et al. Primary health care as a foundation for strengthening health systems in low-and middle-income countries. J Gen Intern Med. 2017;32(5):566-71.
29. Hillman ET, Lu H, Yao T, Nakatsu CH. Microbial ecology along the gastrointestinal tract. Microbes Environm. 2017:ME17017.
30. Salek Farrokhi A, Darabi N, Yousefi B, Askandar RH, Shariati M, Eslami M, et al. Is it true that gut microbiota is considered as panacea in cancer therapy? J Cell Physiol. 2019;234(9):14941-50.
31. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121-41.
32. Dimeloe S, Nanzer A, Ryanna K, Hawrylowicz C. Regulatory T cells, inflammation and the allergic response-the role of glucocorticoids and vitamin D. J Steroid Biochem Mol Biol. 2010;120(2-3):86-95.
33. Houghteling PD, Walker WA. Why is initial bacterial colonization of the intestine important to the infant’s and child’s health? J Pediatr Gastroenterol Nutr. 2015;60(3):294.
34. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313.
35. Tlaskalová-Hogenová H, ˇStepánková ˇ R, Kozáková H, Hudcovic T, Vannucci L, Tuˇcková L, et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011;8(2):110.
36. Kobyliak N, Falalyeyeva T, Bodnar P, Beregova T. Probiotics supplemented with omega-3 fatty acids are more effective for hepatic steatosis reduction in an animal model of obesity. Probiot Antimicrob Proteins. 2017;9(2):123-30.
37. Kobyliak N, Falalyeyeva T, Beregova T, Spivak M. Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition. Endokrynol Polska. 2017;68(6):659-67.
38. Kobyliak N, Virchenko O, Falalyeyeva T, Kondro M, Beregova T, Bodnar P, et al. Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats. Biomed Pharmacother. 2017;90:608-14.
39. Ghasemian A, Eslami M, Shafiei M, Najafipour S, Rajabi A. Probiotics and their increasing importance in human health and infection control. Rev Med Microbiol. 2018;29(4): 153-8.
40. Yousefi B, Eslami M, Ghasemian A, Kokhaei P, Salek Farrokhi A, Darabi N, et al. Probiotics importance and their immunomodulatory properties. J Cell Physiol. 2019;234(6): 8008-18.
41. Eslami M, Yousefi B, Kokhaei P, Moghadas AJ, Moghadam BS, Arabkari V, et al. Are probiotics useful for therapy of Helicobacter pylori diseases? Comparat Immunol Microbiol Infect Dis. 2019;64:99-108.
42. Yousefi B, Eslami M, Ghasemian A, Kokhaei P, Sadeghnejhad A. Probiotics can really cure an autoimmune disease? Gene Rep. 2019:100364.
43. Eslami M, Yousefi B, Kokhaei P, Hemati M, Nejad ZR, Arabkari V, Namdar A, et al. Importance of probiotics in the prevention and treatment of colorectal cancer. J Cell Physiol. 2019;234(10):17127-43.
44. Ursell LK, Clemente JC, Rideout JR, Gevers D, Caporaso JG, Knight R, et al. The interpersonal and intrapersonal diversity of human associated microbiota in key body sites. J Allergy Clin Immunol. 2012;129(5):1204-8.
45. Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF, et al. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med. 2014;20(9):509-18.
46. Sommer F, Bäckhed F. The gut microbiota--masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227.
47. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268-73.
48. Gaggìa F, Mattarelli P, Biavati B. Probiotics and prebiotics in animal feeding for safe food production. Int J Food Microbiol. 2010;141:S15-28.
49. Canny GO, McCormick BA. Bacteria in the intestine, helpful residents or enemies from within? Infect Immun. 2008;76(8):3360-73.
50. Hotel ACP, Cordoba A. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Prevention. 2001;5(1):1-10.
51. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015;60 suppl 2:S129-34.
52. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr. 2006;83(6):1256-64.
53. Fontana L, Bermudez-rito M, Plaza-iaz J, Munoz-uezada S, Gil A. Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr. 2013;109(S2): S35-50.
54. Reid G. Probiotics and prebiotics---progress and challenges. Int Dairy J. 2008;18(10-11):969-75.
55. Aureli P, Capurso L, Castellazzi AM, Clerici M, Giovannini M, Morelli L. Probiotics and health: an evidence-based review. Pharmacol Res. 2011;63(5):366-76.
56. MacDonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307(5717):1920-5.
57. Todorov SD, Furtado DN, Saad SMI, Gombossy de Melo Franco BD. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain. N Microbiol. 2011;34(4):357-70.
58. Ohland CL, MacNaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol-Gastrointest Liver Physiol. 2010;298(6): G807-19.
59. Resta-Lenert S, Barrett K. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 2003;52(7):988-97.
60. Guarner F, Malagelada J-R. Gut flora in health and disease. Lancet. 2003;361(9356):512-9.
61. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short-chain fatty acids. Nutrients. 2011;3(10):858-76.
62. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003;133(7):2485S-93S.
63. Toma MM, Pokrotnieks J. Probiotics as functional food: microbiological and medical aspects. Acta Univ Latviensis. 2006;710:117-29.
64. Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M. Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J Leukoc Biol. 2008;84(2):468-76.
65. Gourbeyre P, Denery S, Bodinier M. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol. 2011;89(5):685-95.
66. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology. 2004;112(3):352-63.
67. Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol. 2005;174(8):4453-60.
68. Toh ZQ, Anzela A, Tang ML, Licciardi PV. Probiotic therapy as a novel approach for allergic disease. Front Pharmacol. 2012;3:171.
69. Bager P, Melbye M, Rostgaard K, Benn CS, Westergaard T. Mode of delivery and risk of allergic rhinitis and asthma. J Allergy Clin Immunol. 2003;111(1):51-6.
70. Illi S, von Mutius E, Lau S, Nickel R, Grüber C, Niggemann B, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004;113(5):925-31.
71. Iannitti T, Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr. 2010;29(6):701-25.
72. Hougee S, Vriesema AJM, Wijering SC, Knippels LMJ, Folkerts G, Nijkamp FP, et al. Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. Int Arch Allergy Immunol. 2010;151(2):107-17.
73. Repa A, Grangette C, Daniel C, Hochreiter R, HoffmannSommergruber K, Thalhamer J, et al. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine. 2003;22(1):87-95.
74. Kim H, Kwack K, Kim DY, Ji GE. Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model. FEMS Immunol Med Microbiol. 2005;45(2):259-67.
75. Kawase M, He F, Kubota A, Hata JY, Kobayakawa SI, Hiramatsu M, et al. Inhibitory effect of Lactobacillus gasseri TMC0356 and Lactobacillus GG on enhanced vascular permeability of nasal mucosa in experimental allergic rhinitis of rats. Biosci Biotechnol Biochem. 2006;70(12):3025-30.
76. Forsythe P, Inman MD, Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med. 2007;175(6):561-9.
77. Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, Jaudszus A, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy. 2007;37(4):498-505.
78. Ogawa T, Hashikawa S, Asai Y, Sakamoto H, Yasuda K, Makimura Y, et al. A new synbiotic, Lactobacillus casei subsp. casei together with dextran, reduces murine and human allergic reaction. FEMS Immunol Med Microbiol. 2006;46(3):400-9.
79. Takahashi N, Kitazawa H, Iwabuchi N, Xiao JZ, Miyaji K, Iwatsuki, et al. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model. Clin Exp Immunol. 2006;145(1):130-8.
80. Peng S, Lin J-Y, Lin M-Y. Antiallergic effect of milk fermented with lactic acid bacteria in a murine animal model. J Agric Food Chem. 2007;55(13):5092-6.
81. Ezendam J, van Loveren H. Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice. Br J Nutr. 2008;99(1):83-90.
82. Lim LH, Li HY, Huang CH, Lee BW, Lee YK, Chua KY, et al. The effects of heat-killed wild-type Lactobacillus casei Shirota on allergic immune responses in an allergy mouse model. Int Arch Allergy Immunol. 2009;148(4):297-304.
83. Inoue Y, Iwabuchi N, Xiao JZ, Yaeshima T, Iwatsuki K. Suppressive effects of Bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model. Biol Pharm Bull. 2009;32(4):760-3.
84. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105(5):755-64.
85. Ohshima-Terada Y, Higuchi Y, Kumagai T, Hagihara A, Nagata M. Complementary effect of oral administration of L actobacillus paracasei K 71 on canine atopic dermatitis. Vet Dermatol. 2015;26(5):350-e75.
86. Thomas DJ, Husmann RJ, Villamar M, Winship TR, Buck RH, Zuckermann FA, et al. Lactobacillus rhamnosus HN001 attenuates allergy development in a pig model. PLoS One. 2011;6(2):e16577.
87. Jang S-O, Kim HJ, Kim YJ, Kang MJ, Kwon JW, Seo JH, et al. Asthma prevention by Lactobacillus rhamnosus in a mouse model is associated with CD4+ CD25+ Foxp3+ T cells. Allergy Asthma Immunol Res. 2012;4(3):150-6.
88. Tang ML, Ponsonby AL, Orsini F, Tey D, Robinson M, Su EL, et al. Administration of a probiotic with peanut oral immunotherapy: a randomized trial. J Allergy Clin Immunol. 2015;135(3), 737-744.e8.
89. Sistek D, et al. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin Exp Allergy. 2006;36(5):629-33.
90. Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005;60(4):494-500.
91. Ooi L-G, Liong M-T. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci. 2010;11(6):2499-522.
92. Yes¸ilova Y, C¸alka Ö, Akdeniz N, Berktas¸ M. Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol. 2012;24(2):189-93.
93. Niers LE, Timmerman HM, Rijkers GT, van Bleek GM, van Uden NO, Knol EF, et al. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy. 2005;35(11):1481-9.
94. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119(1):184-91.
95. Inoue Y, Torii A, Itoh K, Urisu A, Terada A, Fujisawa T, et al. Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults: a double-blind, randomized, clinical trial. Int Arch Allergy Immunol. 2014;165(4):247-54.
96. Prakoeswa C, Herwanto N, Prameswari R, Astari L, Sawitri S, Hidayati AN, et al. Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Benefic Microbes. 2017;8(5):833-40.
97. Simpson MR, Dotterud CK, Storrø O, Johnsen R, Øien T. Perinatal probiotic supplementation in the prevention of allergy-related disease: 6 year follow up of a randomised controlled trial. BMC Dermatol. 2015;15(1):13.
98. Wang IJ, Wang JY. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clin Exp Allergy. 2015;45(4):779-87.
99. Canani RB, Sangwan N, Stefka AT, Nocerino R, Paparo L, Aitoro R, et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J. 2016;10(3):742.
100. Dupont C, Hol J, Nieuwenhuis EE. An extensively hydrolysed casein-based formula for infants with cows’ milk protein allergy: tolerance/hypo-allergenicity and growth catch-up. Br J Nutr. 2015;113(7):1102-12.
101. Del Giudice MM, Indolfi C, Capasso M, Maiello N, Decimo F, Ciprandi G, et al. Bifidobacterium mixture (B longum BB536, B infantis M 63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma. Italian J Pediatr. 2017;43(1):25.
102. del Giudice MM, Maiello N, Allegorico A, Iavarazzo L, Capasso M, Capristo C, et al. Lactobacillus reuteri DSM 17938 plus vitamin D3 as ancillary treatment in allergic children with asthma. Ann Allergy Asthma Immunol. 2016;117(6):710-2.
103. Dennis-Wall JC, Culpepper T, Nieves C Jr, Rowe CC, Burns AM, Rusch CT, et al. Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial. Am J Clin Nutr. 2017;105(3):758-67.
104. Jerzynska J, Stelmach W, Balcerak J, Woicka-Kolejwa K, Rychlik B, Blauz A, et al. Effect of Lactobacillus rhamnosus GG and vitamin D supplementation on the immunologic effectiveness of grass-specific sublingual immunotherapy in children with allergy. Allergy Asthma Proc. 2016;37(4):324-34.
105. Watts AM, Cox AJ, Smith PK, Besseling-van der Vaart I, Cripps AW, West NP, et al. A specifically designed multispecies probiotic supplement relieves seasonal allergic rhinitis symptoms. J Alternat Complement Med. 2018;24(8):833-40.
106. Liao H-Y, Tao L, Zhao J, Qin J, Zeng GC, Cai SW, et al. Clostridium butyricum in combination with specific immunotherapy converts antigen-specific B cells to regulatory B cells in asthmatic patients. Sci Rep. 2016;6:20481.
107. Smith TD, Watt H, Gunn L, Car J, Boyle RJ. Recommending oral probiotics to reduce winter antibiotic prescriptions in people with asthma: a pragmatic randomized controlled trial. Ann Fam Med. 2016;14(5):422-30.
108. Kim JY, Choi YO, Ji GE. Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. J Microbiol Biotechnol. 2008;18(8):1393-400.
109. Yu J, Jang SO, Kim BJ, Song YH, Kwon JW, Kang MJ, et al. The Effects of Lactobacillus rhamnosus on the Prevention of Asthma in a Murine Model. Allergy Asthma Immunol Res. 2010;2(3):199-205.
110. Marsella R, Santoro D, Ahrens K. Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects. Vet Immunol Immunopathol. 2012;146(2):185-9.
111. Kim HJ, Kim YJ, Lee SH, Yu J, Jeong SK, Hong SJ, et al. Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via CD4(+)CD25(+)Foxp3(+) Tregs. Clin Immunol. 2014;153(1):178-86.
112. Wu CT, et al. Effects of immunomodulatory supplementation with Lactobacillus rhamnosus on airway inflammation in a mouse asthma model. J Microbiol Immunol Infect. 2016;49(5):625-35.
113. Liu MY, Yang ZY, Dai WK, Huang JQ, Li YH, Zhang J, et al. Protective effect of Bifidobacterium infantis CGMCC313-2 on ovalbumin-induced airway asthma and beta-lactoglobulin induced intestinal food allergy mouse models. World J Gastroenterol. 2017;23(12):2149-58.
114. Wang X, Hui Y, Zhao L, Hao Y, Guo H, Ren F, et al. Oral administration of Lactobacillus paracasei L9 attenuates PM2.5- induced enhancement of airway hyperresponsiveness and allergic airway response in murine model of asthma. PloS one. 2017;12(2):e0171721.
115. Holowacz S, Guinobert I, Guilbot A, Hidalgo S, Bisson JF. A mixture of five bacterial strains attenuates skin inflammation in mice. Antiinflamm Antiallergy Agents Med Chem. 2018;17(2):125-37.
116. Zhang J, Ma JY, Li QH, Su H, Sun X. Lactobacillus rhamnosus GG induced protective effect on allergic airway inflammation is associated with gut microbiota. Cell Immunol. 2018;332:77-84.
117. Kim IS, Lee SH, Kwon YM, Adhikari B, Kim JA, Yu DY, et al. Oral Administration of beta-Glucan and Lactobacillus plantarum Alleviates Atopic Dermatitis-Like Symptoms. J Microbiol Biotechnol. 2019;29(11):1693-706.
118. Anatriello E, Cunha M, Nogueira J, Carvalho JL, Sá AK, Miranda M, et al. Oral feeding of Lactobacillus bulgaricus N45.10 inhibits the lung inflammation and airway remodeling in murine allergic asthma: Relevance to the Th1/Th2 cytokines and STAT6/T-bet. Cell Immunol. 2019;341:103928.
119. Wang W, Luo X, Zhang Q, He X, Zhang Z, Wang X, et al. Bifidobacterium infantis relieves allergic asthma in mice by regulating Th1/Th2. Med Sci Monitor. 2020;26:e920583.
120. Marlow G, Han DY, Wickens K, Stanley T, Crane J, Mitchell EA, et al. Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors. Pediatr Allergy Immunol. 2015;26(3):262-71.
121. Scalabrin D, Harris C, Johnston WH, Berseth CL. Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up. Eur J Pediatr. 2017;176(2):217-24.
122. Cabana MD, McKean M, Caughey AB, Fong L, Lynch S, Wong A, et al. Early probiotic supplementation for eczema and asthma prevention: a randomized controlled trial. Pediatrics. 2017;140(3).
123. Harata G, Kumar H, He F, Miyazawa K, Yoda K, Kawase M, et al. Probiotics modulate gut microbiota and health status in Japanese cedar pollinosis patients during the pollen season. Eur J Nutr. 2016:56.
124. Ro ADB, Simpson MR, Rø TB, Storrø O, Johnsen R, Videm V, et al. Reduced Th22 cell proportion and prevention of atopic dermatitis in infants following maternal probiotic supplementation. Clin Exp Allergy. 2017;47(8):1014-21.
Article Sidebar
Published
Dec 15, 2020
Article Details
How to Cite
Eslami, M., Bahar, A., Keikha, M., Karbalaei, M., Kobyliak, N., & Yousefi, B. (2020). Probiotics function and modulation of the immune system in allergic diseases. Allergologia Et Immunopathologia, 48(6), 771-788. https://all-imm.com/index.php/aei/article/view/142
Section
Review Article
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
Eslami, M., Bahar, A., Keikha, M., Karbalaei, M., Kobyliak, N., & Yousefi, B. (2020). Probiotics function and modulation of the immune system in allergic diseases. Allergologia Et Immunopathologia, 48(6), 771-788. https://all-imm.com/index.php/aei/article/view/142